Abstract Search

ea0037ep268 | Calcium and Vitamin D metabolism | ECE2015

Patients with new onset diabetes after liver transplantation have higher sclerostin levels that tend to decrease after an oral glucose tolerance test

Diaz-Guerra Guillermo Martinez , Miguel Gonzalo Allo , Ramos Mercedes Aramendi , Librizzi Soledad , Iglesias Sonsoles Guadalix , Fernandez Elena Garcia , Carranza Federico Hawkins

Introduction: Decreased bone formation has been proposed as a mechanism involved in the higher risk of fractures in diabetic patients. Some clinical studies have found that sclerostin (SCL, a negative regulator of bone formation) is increased in diabetic patients. However, there is no information about the relationship between SCL and new onset diabetes after transplantation (NODAT). The aim of our study is to evaluate serum SCL levels in a cohort of patients with liver transp...

0 shares

ePoster

Endocrine Abstracts

Patients with new onset diabetes after liver transplantation have higher sclerostin levels that tend to decrease after an oral glucose tolerance test

BiosciAbstracts